Stay updated on Checkpoint Inhibition+Radiation in Pancreatic/Biliary Cancer Clinical Trial
Sign up to get notified when there's something new on the Checkpoint Inhibition+Radiation in Pancreatic/Biliary Cancer Clinical Trial page.

Latest updates to the Checkpoint Inhibition+Radiation in Pancreatic/Biliary Cancer Clinical Trial page
- ChecktodayChange DetectedThe study record for CheckPAC is displayed, with details on its pancreatic and biliary tract cancer trial, including eligibility criteria, treatment plans, measured outcomes, locations, and record dates.SummaryDifference54%

- Check7 days agoChange DetectedThe footer now identifies the site as revision v3.8.0 instead of v3.7.2; the page still displays a 403 Forbidden error rather than the study record.SummaryDifference0.2%

- Check14 days agoChange DetectedA banner announces that NIH is transitioning to use “Super Intelligence” instead of “Artificial Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check21 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check28 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1 on the 403 Forbidden page.SummaryDifference0.2%

- Check49 days agoChange DetectedAccess to the study record at NCT02866383 is blocked by a 403 Forbidden page, so the study details cannot be viewed. The page still renders site chrome (header, navigation, and footer) but no study information.SummaryDifference19%

Stay in the know with updates to Checkpoint Inhibition+Radiation in Pancreatic/Biliary Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Checkpoint Inhibition+Radiation in Pancreatic/Biliary Cancer Clinical Trial page.